Mitral annular systolic velocity as a marker of preclinical systolic dysfunction among patients with arterial hypertension

Hypertension (HTN) is the most common cardiovascular disease and a major public health problem in both developed and developing countries[1]. Worldwide, high blood pressure is estimated to cause 7.1 million deaths every year, which represents approximately 13% of the global overall mortality. Approximately 62% of strokes and 49% of heart attacks are caused by high blood pressure[2]. HTN causes 5 million premature deaths a year worldwide. Typically, it begins without clinical symptoms, which makes early diagnosis and treatment difficult. Later in the course of the disease, left ventricular (LV) hypertrophy and DD develop, if no appropriate therapy for HTN is given in time. The most common symptoms in this stage of the disease are dyspnea and fatigue, initially on exertion and later at rest. The underlying mechanism is elevated LV filling pressure, which leads to different degrees of pulmonary congestion[3].

However, some studies suggest that minimal systolic impairment in the longitudinal contraction of the LV contribute to the above mentioned symptoms in patients with HTN especially when DD is presented[4‐9]. The dilemma is how to study this early changes in longitudinal systolic function.

There is great methodological heterogeneity in determining myocardial velocities. New data have come from a recent expert consensus statement of American Society of Echocardiography (ASE) and European Association of Echocardiography (EAE) regarding currently available and evolving echocardiographic techniques that allow the quantitative assessment of cardiac mechanics via image-based analysis[10]. In summary, the consensus advocate using the well-studied spectral pulsed wave TDI. Other techniques that allow quantitative assessment of myocardial function via image-based analysis are not suitable for everyday practice because they require advanced levels of skill, lack standardization and are time-consuming. TDI has emerged as one of the most powerful prognosticators for cardiovascular disease in the realm of non-invasive cardiac imaging[11‐13]. The ability to quantify long-axis function of the myocardium in a reproducible manner has also significantly refined the assessment of LV function.

The aim of this study was to investigate mitral annular systolic velocity by TDI as a marker of preclinical systolic dysfunction among patients with HTN and determine the influence of age, gender and DD.

Single center cross-sectional analysis of 3 populations (Healthy, HTN, and DD pts.). Subjects were randomly selected between September 2007 and August 2011 from outpatient clinic and hospitalized patients at the Department of Cardiology and Intensive Care at Military Medical Academy, Sofia, Bulgaria. In this study were enrolled 299 patients with HTN without DD, 297 patients with HTN with DD and 100 aged and gender-matched healthy subjects (Table1). All the patients (n=696) were in sinus rhythm and had a preserved LV ejection fraction (LVEF). There were no patients with signs and symptoms of coronary heart disease, diabetes mellitus or more than a mild valvular heart disease. The basal demographics and clinical parameters are presented on the Table2. All participants signed an informed consent form. Assessment of participants was performed by experienced cardiologists using a standard protocol, including questions on medical history, family history, cardiovascular risk factors, diabetes mellitus history, alcohol intake, physical activity and drug history. A physical examination was performed, which included blood pressure, anthropometric measurements, and an electrocardiogram. The standard laboratory blood tests were performed to identify subjects with diabetes mellitus (fasting blood glucose), dyslipidemia (cholesterol, LDL, HDL, TG), anemia (Hb), significant liver (AST, ALT, GGT, bilirubin) and kidney disease (creatinine, urea). After that the eligible subjects were invited to undergo echocardiography. Echocardiography was performed in a left lateral decubitus position, with a digital commercial harmonic imaging ultrasound system, АLOKA PROSOUND SSD5500 SV, equipped with a 2.5 MHz phased-array transducer. The images were acquired during a breath hold. LV dimensions were obtained in the parasternal short axis view, and LV mass was calculated using the Devereaux formula and indexed to height to give the LV mass index (LVMI). LV hypertrophy was investigated by LVMI and the thickness of the walls. The EF was assessed using the biplane Simpson’s method and assume to be preserved when it was equal or more than 55%[14]. Left atrial volume was calculated from 3 measurements of left atrial dimensions using the formula for an ellipse and indexed to body surface area to obtain the left atrial volume index (LAVI). Diastolic function of the LV was assessed using the following indices: ratio E/A, Valsalva maneuver ΔE/A, ratio E/e′, LAVI, pulmonary artery systolic pressure (PAS), IVRT/T _E-e′ and Ar-A[15].

Myocardial velocities were measured on-line using spectral pulse wave TDI. The sample volume was acquired using low velocity, high-intensity myocardial signals at a high frame rate (>150 MHz). The imaging angle was adjusted to ensure as near to a parallel alignment of the beam as possible with the myocardial segment of interest. The longitudinal contraction of the LV was investigated by the average peak systolic velocity of the mitral annulus (Sm_avg) using two positions, septal and lateral, from the apical 4-chamber view (Figure1, Figure2). In accordance with the study protocol, 3 consecutive complexes were analyzed, and the mean value was calculated. After each evaluation, the results were processed with the АLOKA D4D software and digitally stored (post-processing) to evaluate the reliability of the results. Two experienced echocardiographers evaluated the results of 10 randomly selected participants from every group, independently from one another, for the analysis of intra- and inter-observer variability.

The main goal of the statistical analysis was to investigate the significance of the variances of Sm_(avg) in the observes groups. We used repeated measures ANOVA and multiple regressions.

ANOVA generates 3 tests. The first one (sphericity) refers to the differences between serial measurements of Sm_(avg). The results showed that the variances of velocities are reliable to investigate in the whole study population. The second test (between subjects effects) refers to the variations in Sm_(avg) when the source are age and gender. According to the results, we can state that age and gender significantly influent on the velocities variations. The third test (within subject’s effects) precisely presents the interactions of HTN and DD with the age and gender. We found that the variances of velocities mainly depend on the group membership of the subjects. It means that HTN and DD are independents factors whose influence superimposes those of the age and gender (Table3).

The multiple regressions showed a strong negative correlation between aging and the longitudinal contraction of LV. It can be concluded that aging is a strong factor, significantly related to the decrease of Sm_(avg) in every group. We found a higher Sm_(avg) in males compared with females, as well as a step-wise decrease of Sm_(avg) with aging (Table4).

Analysis showed significant differences in Sm_(avg) between controls and patients with HTN. In subjects with HTN without DD, there was a significant step-wise reduction in Sm_(avg) for every grade of HTN (Table5). Similarly, in patients with HTN and DD, velocity was substantially lower for every grade of DD (Table6). The data showed limits between different groups (normal subjects, HTN, and DD), which are well stratified by velocity. According to the analysis, the control group had Sm_(avg) of more than 10.2 cm/s. The patients with HTN without DD demonstrate Sm_(avg) in the boundaries of 10.2-9.9 cm/s when considering gender and level of HTN. That is, younger males with mild HTN, will have higher velocities compared with older females with moderate or severe HTN who will have lower velocities. In patients with already developed DD, Sm_(avg) falls below 9.9 cm/s. Our data show that the limit is below 9.8 cm/s when considering gender and the magnitude of DD. This means that younger, male patients with DD-impaired relaxation will be situated in the upper end of this limit in contrast to older females who have pseudonormalization or restriction, who will be positioned in the lower end of the boundary.

The underlying explanation of the above scheme is that there is age and gender-dependent changes in velocity superimpose those due to HTN and DD (Figure3). According to our data, if Sm_(avg) is less than 10.2 cm/s the probability of developing early longitudinal systolic dysfunction as a result of HTN is higher. Likewise, if Sm_(avg) is less than 9.8 cm/s, the probability of developing DD due to HTN is also higher. This is a simple two-cutoff approach for detection of the early changes in LV longitudinal systolic function using Sm_(avg).

Although our study is not innovative in nature, as it repeats some of the conclusions achieved more than ten years ago, it confirms the hypothesis that in its development, HTN leads to early changes in the global systolic function of the LV. We concluded that the patients with HTN develop a step-wise reduction in the global systolic function, which is age and gender dependent, and more importantly, that this happens before the onset of DD. The question is how to avoid reaching this stage, and how to diagnose the patient at risk of developing heart failure with preserved and later reduced EF. The general conclusion of the study regards the existence of three trends for the reduction of the long axis systolic function. The first trend is one of age, the second depends on gender and the third concerns the interdependency of HTN and DD. All three trends interact in such a way that the estimated Sm_(avg) is a reflection of the gender, age and grade of HTN and the magnitude of DD of the corresponding subject (Figure4).

In summary, our results show that HTN and its evolution are related to a slight reduction in the longitudinal systolic contraction of the LV, and the subsequent DD adds further decline to the already existing mild systolic dysfunction. This finding alone cannot account for the clinical symptoms in patients, such as breathlessness and fatigue, for example. In most cases, these symptoms occur as a result of elevated LV filling pressure. Therefore the importance of our results lies in the fact that these initial changes in systolic contraction of the LV could be used as an early sign that should prompt optimization of the treatment of HTN. The strength of the study is the analysis of incremental changes in longitudinal contraction but not so many the classification of the degree of systolic dysfunction. It is critically important to discover this initial contractile dysfunction when the EF is still preserved. The aim of treatment is to prevent the further development of DD and, thus, heart failure. It is reasonably to plane and conduct a prospective study which elucidate whether the different therapeutic strategy could influent to this initial preclinical systolic dysfunction. We could suggest benefits following this hypothesis, but at this point of view couldn’t prove it.

Finally, we should emphasize that the investigation of early changes in the longitudinal systolic function of the LV is always experience dependent but not time-consuming, and all cardiologists should be trained in it.

The results of this study show that HTN and its evolution are related to slight impairments of the longitudinal systolic function. Without a prompt change in therapy the next stage is worsens the global contractility due to further progression to DD. The main objective should be to diagnose this preclinical systolic dysfunction early in the course of the HTN before there are morphological changes in the LV. Adjustments to therapy should be initiated before DD develops.